InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,773.83
(
1.53%
)

Replies to post #220399 on Avid Bioservices Inc (CDMO)

Replies to #220399 on Avid Bioservices Inc (CDMO)
icon url

DewDiligence

05/26/15 8:45 AM

#220416 RE: md1225 #220399

[OT]—OCRX’s STOP-HE is considered a pivotal trial for the HE indication. So, it’s effectively a phase-3 even though listed on clincialtrials.gov as phase-2b.